Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism

Thrombosis Research

Volumn 119, Issue 4, 2007, Pages 525-529

  Ferretti, Gianluigi ^a   Bria, Emilio ^a   Giannarelli, Diana ^a   Carlini, Paolo ^a   Felici, Alessandra ^a   Mandalà, Mario ^b   Ciccarese, Mariangela ^a   Papaldo, Paola ^a   Fabi, Alessandra ^a   Cognetti, Francesco ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b TREVIGLIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; BEMIPARIN; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DEEP VEIN THROMBOSIS; DRUG SAFETY; EMBASE; HUMAN; LETTER; LONG TERM CARE; LUNG EMBOLISM; MANTEL HAENSZEL TEST; MEDLINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS; TIME FACTORS;

EID: 33846462072     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.04.009     Document Type: Letter

References (15)

1. Lee A.Y., Levine M.N., Baker R.I., Bowden C., Kakkar A.K., Prins M., et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349 2 (2003) 146-153
2. Pini M., Aiello S., Manotti C., Pattacini C., Quintavalla R., Poli T., et al. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 72 2 (1994) 191-197
3. Das S.K., Cohen A.T., Edmondson R.A., Melissari E., and Kakkar V.V. Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial. World J Surg 20 (1996) 521-526
4. Gonzalez-Fajardo J.A., Arreba E., Castrodeza J., Perez J.L., Fernandez L., Agundez I., et al. Venographic comparison of subcutaneous low-molecular-weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. J Vasc Surg 30 (1999) 283-290
5. Lopaciuk S., Bielska-Falda H., Noszczyk W., Bielawiec M., Witkiewicz W., Filipecki S., et al. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Thromb Haemost 81 (1999) 26-31
6. Veiga F., Escriba A., Maluenda M.P., Lopez Rubio M., Margalet I., Lezana A., et al. Low-molecular weight heparin (Enoxaparin) versus oral anticoagulant therapy (Acenocumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial. Thromb Haemost 84 (2000) 559-564
7. Lopez-Beret P., Orgaz A., Fontcuberta J., Doblas M., Martinez A., Lozano G., et al. Low-molecular weight heparin versus oral anticoagulant in the long-term treatment of deep venous thrombosis. J Vasc Surg 33 (2001) 77-90
8. Meyer G., Marjanovic Z., Valcke J., Lorcerie B., Gruel Y., Solal-Celigny P., et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 162 15 (2002) 1729-1735
9. Hull R.D., Pineo G.F., Mah A.F., and Brant R.F. A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium. Blood 100 11 (2002) 148a #556
10. Kakkar V.V., Gebska M., Kadziola Z., Saba N., and Carrasco P. Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis. Thromb Haemost 89 4 (2003) 674-680
11. Heijden JF, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev; The Cochrane Library 2004, Issue 4. John Wiley and Sons, Ltd.
12. Parmar M.K., Torri V., and Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17 24 (1998) 2815-2834
13. Takkouche B., Cadarso-Suarez C., and Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 150 2 (1999) 206-215
14. Bria E., Giannarelli D., Felici A., Peters W.P., Nistico C., Vanni B., et al. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma: pooled analysis of 2805 patients. Cancer 103 4 (2005) 672-679
15. Iorio A., Guercini F., and Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 1 9 (2003) 1906-1913